Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
For patients undergoing bladder preservation therapy with TMT, how do you manage the urinary urgency and frequency during and after treatment?
Related Questions
Do distant lymph nodes from metastatic prostate cancer (retroperitoneal and SCV) count as oligometastatic disease?
What radiation treatments would you offer an older man with unfavorable intermediate-risk prostate cancer, with comorbid conditions, if you don't feel he is a good candidate for full-course radiation therapy with ADT?
How would you manage a patient with PSA persistence after RALP demonstrating metastasis in regional lymph nodes without further evidence of disease on bone or CT scans?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
Would you offer palliative radiation to a patient with hematuria from squamous metaplasia of the bladder that is not responding to endoscopic therapy?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
Would you treat someone following FLAME protocol for prostate cancer without fiducials if using daily CBCT?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
Do you recommend radiation in a patient with BAP1Tumor Predisposition Syndrome with prior RCC with recurrent brain met after previous resection?
How do you manage significant gas in patients undergoing pelvic radiotherapy?
